<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04443205</url>
  </required_header>
  <id_info>
    <org_study_id>PO20090</org_study_id>
    <nct_id>NCT04443205</nct_id>
  </id_info>
  <brief_title>Relevance of Ultrasound Screening for Foetal Macrosomia</brief_title>
  <acronym>USmacro</acronym>
  <official_title>Relevance of Ultrasound Screening for Foetal Macrosomia and Description of Its Management in Champagne-Ardenne</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Management of fetal macrosomia is based on a suspicion of macrosomia (no certainty before
      birth). This management is an artificial induction of labour for an earlier delivery and
      therefore a lower fetal weight gain. Several studies have already shown that ultrasound
      performed during the third trimester of pregnancy was not a perfect tool for this screening.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to describe management of women whose child is macrosomal but has not
      been screened g using ultrasound during the third trimester of pregnancy.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Foetal macrosomia</measure>
    <time_frame>Baseline</time_frame>
    <description>estimated weight above the 90th percentile of the curves of the French College of Fetal Ultrasound during the third trimester ultrasound</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>no macrosomy</arm_group_label>
    <description>pregnant women whose child is not macrosomal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>screened macrosomy</arm_group_label>
    <description>pregnant women whose child is macrosomal and have been screened g using ultrasound during the third trimester of pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no screened macrosomy</arm_group_label>
    <description>pregnant women whose child is macrosomal and havenot been screened g using ultrasound during the third trimester of pregnancy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data record</intervention_name>
    <description>Data record</description>
    <arm_group_label>no macrosomy</arm_group_label>
    <arm_group_label>no screened macrosomy</arm_group_label>
    <arm_group_label>screened macrosomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria : Patients (consecutive inclusions) :

        Women pregnant Women followed in the gynaecology and obstetrics department of the CHU of
        Reims, the CHG of Charleville Mézières or the CHG of Chalons en Champagne.

        Women for which the delivery is planned in the gynaecology and obstetrics department of the
        Reims University Hospital, the Charleville Mézières General Hospital or the Chalons en
        Champagne General Hospital.

        Non-inclusion criteria Women without ultrasound dating scan in the first trimester. Women
        having a contraindication to labour or vaginal delivery Women with a scarred uterus Women
        having a history of shoulder dystocia or obstetric trauma Women having a history of urinary
        or fecal incontinence Women having a history of bad birth experience with high
        psychological impact Women with maternal pathologies (excluding gestational diabetes) Women
        whose fetus is breech Women with twin pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Uzma ISHAQUE</last_name>
    <phone>03 10 73 62 88</phone>
    <phone_ext>0033</phone_ext>
    <email>uishaque@chu-reims.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Damien JOLLY</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Uzma ISHAQUE</last_name>
      <phone>03 10 73 62 88</phone>
      <phone_ext>0033</phone_ext>
      <email>uishaque@chu-reims.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 17, 2020</study_first_submitted>
  <study_first_submitted_qc>June 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2020</study_first_posted>
  <last_update_submitted>June 22, 2020</last_update_submitted>
  <last_update_submitted_qc>June 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fetal Macrosomia</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Shoulder Dystocia</keyword>
  <keyword>induction of labour</keyword>
  <keyword>Cesarean</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Macrosomia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

